Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-08-21

FDA Approved: ALOCRIL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for ALOCRIL (nedocromil sodium) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALOCRIL (NEDOCROMIL SODIUM)

Snippet

SUPPL AP for ALOCRIL (NEDOCROMIL SODIUM)